Michael R Gold1, Claude Daubert2, William T Abraham3, Stefano Ghio4, Martin St John Sutton5, John Harrison Hudnall6, Jeffrey Cerkvenik6, Cecilia Linde7. 1. Medical University of South Carolina, Charleston, South Carolina. Electronic address: goldmr@musc.edu. 2. Department of Cardiology, University Hospital, Rennes, France. 3. The Ohio State University, Columbus, Ohio. 4. Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. 5. University of Pennsylvania Medical Center, Philadelphia, Pennsylvania. 6. Medtronic Inc, Minneapolis, Minnesota. 7. Karolinska University Hospital, Stockholm, Sweden.
Abstract
BACKGROUND:Cardiac resynchronization therapy (CRT) reduces mortality, improves functional status, and induces reverse left ventricular remodeling in selected populations with heart failure (HF). The magnitude of reverse remodeling predicts survival with many HF medical therapies. However, there are few studies assessing the effect of remodeling on long-term survival with CRT. OBJECTIVE: The purpose of this study was to assess the effect of CRT-induced reverse remodeling on long-term survival in patients with mildly symptomatic heart failure. METHODS: The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction trial was a multicenter, double-blind, randomized trial of CRT in patients with mild HF. Long-term follow-up of 5 years was preplanned. The present analysis was restricted to the 353 patients who were randomized to theCRT ON group with paired echocardiographic studies at baseline and 6 months postimplantation. The left ventricular end-systolic volume index (LVESVi) was measured in the core laboratory and was an independently powered end point of the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction trial. RESULTS: A 68% reduction in mortality was observed in patients with ≥15% decrease in LVESVi compared to the rest of the patients (P = .0004). Multivariable analysis showed that the change in LVESVi was a strong independent predictor (P = .0002), with a 14% reduction in mortality for every 10% decrease in LVESVi. Other remodeling parameters such as left ventricular end-diastolic volume index and ejection fraction had a similar association with mortality. CONCLUSION: The change in left ventricular end-systolic volume after 6 months of CRT is a strong independent predictor of long-term survival in mild HF.
RCT Entities:
BACKGROUND: Cardiac resynchronization therapy (CRT) reduces mortality, improves functional status, and induces reverse left ventricular remodeling in selected populations with heart failure (HF). The magnitude of reverse remodeling predicts survival with many HF medical therapies. However, there are few studies assessing the effect of remodeling on long-term survival with CRT. OBJECTIVE: The purpose of this study was to assess the effect of CRT-induced reverse remodeling on long-term survival in patients with mildly symptomatic heart failure. METHODS: The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction trial was a multicenter, double-blind, randomized trial of CRT in patients with mild HF. Long-term follow-up of 5 years was preplanned. The present analysis was restricted to the 353 patients who were randomized to the CRT ON group with paired echocardiographic studies at baseline and 6 months postimplantation. The left ventricular end-systolic volume index (LVESVi) was measured in the core laboratory and was an independently powered end point of the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction trial. RESULTS: A 68% reduction in mortality was observed in patients with ≥15% decrease in LVESVi compared to the rest of the patients (P = .0004). Multivariable analysis showed that the change in LVESVi was a strong independent predictor (P = .0002), with a 14% reduction in mortality for every 10% decrease in LVESVi. Other remodeling parameters such as left ventricular end-diastolic volume index and ejection fraction had a similar association with mortality. CONCLUSION: The change in left ventricular end-systolic volume after 6 months of CRT is a strong independent predictor of long-term survival in mild HF.
Authors: Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters Journal: J Am Coll Cardiol Date: 2002-11-06 Impact factor: 24.094
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Silvia G Priori; Etienne Aliot; Carina Blomstrom-Lundqvist; Leo Bossaert; Gunter Breithardt; Pedro Brugada; John A Camm; Riccardo Cappato; Stuart M Cobbe; Carlo Di Mario; Barry J Maron; William J McKenna; Anders K Pedersen; Ursula Ravens; Peter J Schwartz; Maria Trusz-Gluza; Panos Vardas; Hein J J Wellens; Douglas P Zipes Journal: Eur Heart J Date: 2003-01 Impact factor: 29.983
Authors: Claudia Ypenburg; Rutger J van Bommel; C Jan Willem Borleffs; Gabe B Bleeker; Eric Boersma; Martin J Schalij; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2009-02-10 Impact factor: 24.094
Authors: Wilson S Colucci; Theodore J Kolias; Kirkwood F Adams; William F Armstrong; Jalal K Ghali; Stephen S Gottlieb; Barry Greenberg; Michael I Klibaner; Marrick L Kukin; Jennifer E Sugg Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: James B Young; William T Abraham; Andrew L Smith; Angel R Leon; Randy Lieberman; Bruce Wilkoff; Robert C Canby; John S Schroeder; L Bing Liem; Shelley Hall; Kevin Wheelan Journal: JAMA Date: 2003-05-28 Impact factor: 56.272
Authors: Cecilia Linde; William T Abraham; Michael R Gold; Martin St John Sutton; Stefano Ghio; Claude Daubert Journal: J Am Coll Cardiol Date: 2008-11-07 Impact factor: 24.094
Authors: Larisa G Tereshchenko; Alan Cheng; Jason Park; Nicholas Wold; Timothy E Meyer; Michael R Gold; Suneet Mittal; Jagmeet Singh; Kenneth M Stein; Kenneth A Ellenbogen Journal: Heart Rhythm Date: 2015-08-10 Impact factor: 6.343
Authors: Ravi Shah; Olivia Ziegler; Ashish Yeri; Xiaojun Liu; Venkatesh Murthy; Dustin Rabideau; Chun Yang Xiao; Kristina Hanspers; Arianna Belcher; Michael Tackett; Anthony Rosenzweig; Alexander R Pico; James L Januzzi; Saumya Das Journal: Circ Heart Fail Date: 2018-02 Impact factor: 8.790
Authors: Michael E Nassif; Yuanyuan Tang; John G Cleland; William T Abraham; Cecilia Linde; Michael R Gold; James B Young; J Claude Daubert; Lou Sherfesee; Dan Schaber; Anthony S L Tang; Philip G Jones; Suzanne V Arnold; John A Spertus Journal: Circ Heart Fail Date: 2017-10 Impact factor: 8.790